HUC1-394 is a peptide-based eye drop for dry eyes, licensed from NOVACELL Technology. According to the company, HUC1-394 ...
Belite Bio has released topline results from the global phase 3 DRAGON trial of Tinlarebant in patients with Stargardt ...
The US Patent and Trademark Office has issued a new patent (US Patent No. 12,472,263) on additional and novel formulations of ...
Prevent Blindness has declared the first week of December as its 5th annual geographic atrophy (GA) week to educate the ...
The CEO of Dean McGee Eye Institute reflects on the program’s milestones, global partnerships, and the future of ...
Lid margin collarettes are common in moderate-to-severe DED, but most do not progress over time. No link was found between collarettes and dry eye symptoms. DED signs were more severe in eyes with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback